Suvretta Capital Management

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 16
Average round size
info
The average size of a deal this fund participated in
$338M
Portfolio companies 16
Lead investments 0
Exits 7
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Biopharma

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Suvretta Capital Management:
Typical Co-investors
Suvretta Capital Management is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Suvretta Capital Management:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Bairong Beijing, Beijing, China
eCandy.com -
Galaxy Capital China, Jiangsu, Suzhou
GO Capital Fund Canada, Montréal, Quebec
Hafnium Hafaway -
Hubei Qianyong Touzi China, Hubei, Wuhan
Institute for Interdisciplinary Information Core Technology -
Khattar Holdings Central, Central Region, Singapore
Kogito Ventures Mazowieckie, Poland, Warsaw
LTS Japan, Tokyo
New Kent Capital LLC. -
RBC Capital Markets Albany, New York, United States
Reinet Investments S.C.A. Luxembourg, Luxembourg
Ronald Lauder Ventures -
Runyang Group China, Guangdong Province, Luohu District
Slate Path Capital New York, New York, United States
Synopsys California, Mountain View, United States
UCLA Investment Company California, Los Angeles, United States
Wenxin Shiye China, Guangdong, Jiangxi
Yabeo Capital Bavaria, Bayern, Germany

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

connectRN

Health Care
Hospital
Marketplace
Medical
Mobile Apps
Nursing and Residential Care
$76M08 Dec 2021 Boston, Massachusetts, United States

Freenome

Biotechnology
Health Care
Health Diagnostics
Personal Health
$300M07 Dec 2021 South San Francisco, California, United States

Roivant Sciences

Biopharma
Biotechnology
Health Care
Pharmaceutical
Product Research
$200M01 Oct 2021 New York, New York, United States

Alight Solutions

Consulting
Human Resources
Professional Services
Software
$1B06 Jul 2021 Lincolnshire, Illinois, United States

Point Biopharma

Biopharma
Biotechnology
Therapeutics
$165M01 Jul 2021 Indianapolis, Indiana, United States

Turntide Technologies

Energy Efficiency
GreenTech
Industrial Automation
Internet of Things
Software
$225M30 Jun 2021 Sunnyvale, California, United States

Arcellx

Biopharma
Health Care
Pharmaceutical
$115M13 Apr 2021 Maryland, United States

Paysafe

Accounting
Business Development
E-Commerce
Financial Services
FinTech
Mobile
Mobile Payments
Payments
Risk Management
$2B31 Mar 2021 London, England, United Kingdom

Pipeline Therapeutics

Pharmaceutical
$80M11 Feb 2021 San Diego, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Suvretta Capital Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: